Cargando…
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
The goal of this article is to provide recommendations for the diagnosis and treatment of muscle-invasive and metastatic bladder cancer. The diagnosis of muscle-invasive bladder cancer is made by pathologic evaluation after transurethral resection. Recently, a molecular classification has been propo...
Autores principales: | Lázaro, M., Gallardo, E., Doménech, M., Pinto, Á., del Alba, A. González, Puente, J., Fernández, O., Font, A., Lainez, N., Vázquez, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138255/ https://www.ncbi.nlm.nih.gov/pubmed/27900539 http://dx.doi.org/10.1007/s12094-016-1584-z |
Ejemplares similares
-
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
por: González del Alba, A., et al.
Publicado: (2018) -
SEOM Clinical Guideline in ovarian cancer (2016)
por: Santaballa, A., et al.
Publicado: (2016) -
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023) -
SEOM Clinical guidelines for the treatment of metastatic prostate cancer
por: Cassinello, J., et al.
Publicado: (2014) -
SEOM clinical guidelines for the treatment of renal cell carcinoma
por: Bellmunt, J., et al.
Publicado: (2014)